• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Archives for Medicines for Malaria Venture (MMV)

Non-Profit Offers Free Kits of Potential Malaria Cures for Researchers to Study

December 8, 2013 By Malaria.com Leave a Comment

A nonprofit called Medicines for Malaria Venture (MMV) is sending free kits of potential malaria cures for researchers. It's called The Malaria Box, and it is the result of a high-throughput screen done by MMV and cooperating pharmaceutical companies. All you have to do is send your request, along with a summary of your research and how you plan to share the data. The box contain samples of 400 … [Read more...]

Filed Under: Malaria Research Tagged With: Medicines for Malaria Venture (MMV), The Malaria Box

SMS for Life Uses Mobile Phones to Increase Access to Essential Antimalaria Medications

November 11, 2013 By Malaria.com Leave a Comment

SMS for Life harnesses everyday technology to improve access to essential malaria medicines in rural areas of developing countries. It uses a combination of mobile phones, SMS messages and electronic mapping technology to track weekly stock levels at public health facilities in order to: Eliminate stock-outs Increase access to essential medicines Reduce the number of deaths from … [Read more...]

Filed Under: Malaria Videos Tagged With: Medicines for Malaria Venture (MMV), Mobile Technology, Novartis, Roll Back Malaria Partnership, SMS for Life, Tanzania, Tanzanian Ministry of Health and Social Welfare

New Drug Synriam Approved to Treat Malaria in India

July 6, 2012 By Malaria.com Leave a Comment

A new drug to treat malaria, Synriam, was launched in India by Ranbaxy Laboratories Limited. The drug will provide additional options for malaria treatment as  traditional drugs become increasingly ineffective against the deadly malarial parasite because of acquired resistance to available medications. Taken as a tablet once a day for three days, Synriam may be more effective, cheaper, and have … [Read more...]

Filed Under: Malaria News Tagged With: arterolane, Courtney Fletcher, Jonathan Vennerstrom, Malaria Treatment, Medicines for Malaria Venture (MMV), Ranbaxy, Tim Wells, University of Nebraska Medical Center (UNMC)

Higher Research Funding Leads to 4x Rise in New Anti-Malaria Product Pipeline

June 29, 2011 By Malaria.com Leave a Comment

A new analysis of progress in the global fight against malaria finds a four-fold increase in annual funding for malaria research and development (R&D) in just 16 years—increasing from US$121 million in 1993 to US$612 million in 2009, with a particularly rapid increase since 2004. The funding has generated the strongest pipeline of malaria control and prevention products in history. The … [Read more...]

Filed Under: Malaria News Tagged With: Foundation for Innovative New Diagnostics (FIND), Innovative Vector Control Consortium (IVCC), Medicines for Malaria Venture (MMV), Policy Cures, Roll Back Malaria, the PATH Malaria Vaccine Initiative

“SMS for Life” Malaria Initiative for Tanzania Announced

April 18, 2011 By Malaria.com Leave a Comment

In commemoration of World Malaria Day 2011 (25 April), organizations in an innovative public-private initiative announce the nationwide roll-out of a unique malaria treatment access initiative, "SMS for Life," across the United Republic of Tanzania. The roll-out follows a successful pilot project where mobile and electronic mapping technology was used to track the stock levels of anti-malarial … [Read more...]

Filed Under: Malaria News Tagged With: Hadji Hussein Mponda, IBM, Jim Barrington, Medicines for Malaria Venture (MMV), Novartis, Roll Back Malaria, SMS for Life, Swiss Agency for Development and Cooperation, Tanzania, Tanzanian Ministry of Health and Social Welfare, Vodacom, Vodafone, World Health Organization (WHO), World Malaria Day

Anacor Pharmaceuticals Enters Development Agreement with Medicines for Malaria Venture (MMV)

March 17, 2011 By Malaria.com 1 Comment

Anacor Pharmaceuticals has entered into a development agreement with Medicines for Malaria Venture (MMV) to develop Anacor’s compound AN3661 for the treatment of malaria. Under the agreement, Anacor and MMV will work together on the development of AN3661 through human proof-of-concept studies. AN3661 was developed as part of a research agreement signed by the two parties in April 2010 to … [Read more...]

Filed Under: Malaria News Tagged With: AN3661, Anacor Pharmaceuticals, David Perry, Eurartesim, Medicines for Malaria Venture (MMV), Pyramax

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2025 Malaria.com · Log in